Literature DB >> 22487023

Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group.

P Portela1, L F Jobim, P H Salim, W J Koff, T J Wilson, M R Jobim, G Schwartsmann, R Roesler, M Jobim.   

Abstract

Prostate cancer is the second most common cancer in men, with a significant increase in incidence and mortality in men over 50 years of age. Natural killer cells (NK) are part of the innate immune system recognizing class I HLA molecules on target cells through their membrane receptors, called killer cell immunoglobulin-like receptors (KIR). The aim of our study is to evaluate the association between the KIR genes and HLA alleles in patients with prostate cancer and healthy controls. Two hundred patients with prostate cancer and 185 healthy controls were typed for HLA class I and KIR genes by PCR-SSP. When both groups were compared, no significant differences were found for HLA-C group 1 and group 2, HLA-Bw4, HLA-A3 and A11. No difference was seen either in KIR frequency between patients with prostate cancer and controls. In conclusion, our data suggest no potential role for the KIR gene system in prostate cancer.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487023     DOI: 10.1111/j.1744-313X.2012.01115.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  4 in total

1.  α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.

Authors:  Xi-He Zhang; Xiao-Dong Lian; Zheng-Xi Dai; Hong-Yi Zheng; Xin Chen; Yong-Tang Zheng
Journal:  J Immunol       Date:  2017-08-07       Impact factor: 5.422

2.  KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

Authors:  Yayi He; Paul A Bunn; Caicun Zhou; Dan Chan
Journal:  Oncotarget       Date:  2016-12-13

Review 3.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

4.  Dysregulation of DNA Methylation and Epigenetic Clocks in Prostate Cancer among Puerto Rican Men.

Authors:  Anders Berglund; Jaime Matta; Jarline Encarnación-Medina; Carmen Ortiz-Sanchéz; Julie Dutil; Raymond Linares; Joshua Marcial; Caren Abreu-Takemura; Natasha Moreno; Ryan Putney; Ratna Chakrabarti; Hui-Yi Lin; Kosj Yamoah; Carlos Diaz Osterman; Liang Wang; Jasreman Dhillon; Youngchul Kim; Seung Joon Kim; Gilberto Ruiz-Deya; Jong Y Park
Journal:  Biomolecules       Date:  2021-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.